Patent assignee · FR · COMPANY

SANTEN SAS

15Patents
15Active
15Granted
50Portfolio score

Filing activity: Jun 1, 2007 → Oct 21, 2020 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9555045B2 Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions Human Necessities 6 Active
US9682147B2 Self-preserved oil dispersions comprising boric acid Human Necessities 2 Active
US9072750B2 Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions Human Necessities 2 Active
US9192567B2 Method for treating eye disease or conditions affecting the posterior segment of the eye Human Necessities 1 Active
US11612658B2 Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the same Chemistry; Metallurgy 0 Active
US9220694B2 Emulsion compositions containing cetalkonium chloride Chemistry; Metallurgy 0 Active
US8623852B2 Topical methods and compositions for the treatment of eye diseases and conditions Human Necessities 0 Active
US9107822B2 Water-in oil type emulsion for treating a disease of the eye Chemistry; Metallurgy 0 Active
US11452739B2 Polysaccharides for the treatment of ocular conditions Human Necessities 0 Active
US9616016B2 Method for treating retinal conditions using an intraocular tamponade Human Necessities 0 Active
US9089480B2 Anionic oil-in-water emulsions containing prostaglandins and uses thereof Human Necessities 0 Active
US9956289B2 Emulsion compositions containing quaternary ammonium compounds Chemistry; Metallurgy 0 Active
US10842873B2 Methods for preparing oil-in-water emulsions comprising cetalkonium chloride Chemistry; Metallurgy 0 Active
US9364461B2 Process for manufacturing ophthalmic oil-in-water emulsions Human Necessities 0 Active
US9132071B2 Compositions containing quaternary ammonium compounds Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.